Diadem Biotherapeutics Patents

Patent portfolio assigned to Diadem Biotherapeutics (verified via public assignee records). Estimated patent count: 10. Torrance, CA platform-therapeutics startup engineering extracellular vesicles/exosomes (DECOSTAR platform) for cancer & autoimmune disease (founded 2019, IndieBio/SOSV). Patent analytics (GreyB) credit Diadem with ~10 patents globally (2 granted), incl. US11746138B2, US11578116B2, WO2021159016A1. Preclinical -> no commercial customers.